Sun.May 30, 2021

article thumbnail

Disruption my ass! Tech companies want healthcare dollars

World of DTC Marketing

SUMMARY: Amazon has set its sights on healthcare as it smells another profit opportunity. Google has signed an agreement with the Mayo clinic to help analyze data as they want a slice of healthcare dollars but what’s missing from these tech companies is “the human touch” that patients want. Via The New Republic “whether it believes its own rhetoric—or just smells another profit opportunity—the tech industry shows little sign of slowing its march into the world of commerci

Pharmacy 198
article thumbnail

Beer byproduct mixed with manure proves an excellent pesticide

Scienmag

Byproducts from the beer and agricultural industry have been shown to reduce numbers of root-knot nematodes and increase yields of lettuce crops Credit: Image: Maite Gandariasbeitia et al The use of many chemical fumigants in agriculture have been demonstrated to be harmful to human health and the environment and therefore banned from use. Now, in […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ketamine as a Depression Treatment Saved Me

NY Times

I tried everything to treat my depression. Ketamine is the one thing that worked.

Drugs 112
article thumbnail

Young Arabic speakers offered kid-friendly route into scientific discovery

Scienmag

Credit: Frontiers Arabic speakers worldwide can now access a library of kid-friendly scientific articles thanks to a newly launched educational resource. Penned by leading scientists and published in Arabic by scholarly publisher Frontiers, the online learning resource includes a collection of fascinating scientific articles designed to inspire the next generation of young scientists.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Can Arthritis Be Reversed?

DM Clinical Research

If you’ve been diagnosed with arthritis, then you are probably wondering what’s in store for the future. After all, arthritis can have a major impact on your life. So can arthritis be reversed, or will you need to deal with symptoms in the long term? Read on to learn what the future looks like for arthritis patients. What is Arthritis? While arthritis might sound like one condition, the word is actually an umbrella term that describes different types of joint pain.

Doctors 40
article thumbnail

Oncotarget: Piperlongumine promotes death of retinoblastoma cancer cells

Scienmag

These Oncotarget findings suggest that PL reduces tumor growth and induces cell death by regulating the cell cycle Credit: Correspondence to – Nathalie Allaman-Pillet – nathalie.allaman@gmail.com Oncotarget published “Piperlongumine promotes death of retinoblastoma cancer cells” which reported that while retinoblastoma initiation is triggered by the inactivation of both alleles of the retinoblastoma tumor suppressor gene […].

More Trending

article thumbnail

Oncotarget: Progression in high-risk non-muscle invasive bladder cancer

Scienmag

This Oncotarget study examined the importance of the De Ritis ratio as a prognostic marker in high-risk NMIBC Credit: Correspondence to – Takashi Kawahara – takashi_tk2001@yahoo.co.jp Oncotarget published “A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer” which reported that a recent study revealed that a […].

article thumbnail

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2021 Annual General Meeting held on May 28, 2021

BioTech 365

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2021 Annual General Meeting held on May 28, 2021 ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2021 Annual General Meeting held on May 28, 2021 … Continue reading →

40
article thumbnail

Oncotarget: Activation of plasmacytoid dendritic cells promotes AML-cell fratricide

Scienmag

These Oncotarget findings suggest that the tolerogenic phenotype of pDCs in AML can be reversed Credit: Correspondence to – Jonathan P. Butchar – butchar.2@osu.edu and Susheela Tridandapani – tridandapani.2@osu.edu Oncotarget published “Activation of plasmacytoid dendritic cells promotes AML-cell fratricide” which reported that Interferons have been previously shown to aid in the clearance of AML cells. […].

article thumbnail

Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts

BioTech 365

Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts This newly formed committee of international specialists will advise on the scientific and clinical aspects related to the … Continue reading →

40
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Ecole de technologie superieure welcomes two research chairs specialized in artificial intelligence applied to health

Scienmag

1.5 million in funding over three years from the Fonds de recherche du Québec – Santé (FRSQ) Credit: ETS Thanks to $1.5 million in funding over three years from the Fonds de recherche du Quebec – Sante (FRQS), the Ecole de technologie superieure (ETS) will host two new research chairs on artificial intelligence applied to […].

article thumbnail

GenSight Biologics to Host a Key Opinion Leader Webinar on the Nature Medicine Case Report: Visual Recovery after GS030 Optogenetic Treatment

BioTech 365

GenSight Biologics to Host a Key Opinion Leader Webinar on the Nature Medicine Case Report: Visual Recovery after GS030 Optogenetic Treatment GenSight Biologics to Host a Key Opinion Leader Webinar on the Nature Medicine Case Report: Visual Recovery after GS030 … Continue reading →

article thumbnail

Which pharmaceutical companies have the most SPCs in Estonia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Estonia? appeared first on DrugPatentWatch - Make Better Decisions.

98